Skip to content
BuyandBill.com — Physician Administered Drug Pricing
  • Search
    • Search
    • HCPCS Code Lookup
    • NDC Lookup
    • Drug Price Lookup
  • Drug Codes
    • All Drug Codes
    • A Code
    • C Code
    • J Code
    • P Code
    • Q Code
    • S Code
    • CPT Vaccine Code
    • NOC Code
    • Administration Code
  • Coding References

    • CPT Administration Codes
    • HCPCS Modifiers
    • HCPCS Approvals
    • Medically Unlikely Edits
    • Place of Service Codes
    • NDC Listing Errors
    • SAD Exclusion List
    • Wastage Guidance

    Learn

    • Blog
    • Newsletter
    • Bobbi Buell's Newsletter
    • Glossary
    • Buy-and-Bill Basics
    • Biosimilars
    • 505(b)(2) Drugs
    • Drug Shortages

    Tools

    • Billing Calculator
    • Drug Comparative Graphing
    • Biosimilar Analysis
    • Part B Reimbursement

    Solutions

    • Drug Sponsorship
    • Drug Market Research
  • Subscription Options
    • Contact Us
    • Schedule Consultation
Login
  • Login
  • Register

Drug Alerts and Special Reports

Key reimbursement alerts for office-administered drugs — C-Code, J-Code, NDC, and NCCN alerts plus pricing updates, sent on behalf of pharma manufacturers.

Subscribe To Newsletter

Pricing 02/14/2023

Announcing a new WAC for Nexplanon J7307 - 8/25/22

Announcing a new Wholesale Acquisition Cost (WAC) for NEXPLANON® (etonogestrel implant) 68 mg Radiopaque Announcing a New WAC for NEXPLANON Effective August 18, 2022, the new WAC for NEXPLANON WAC is $1,092.48. Please update your claims processing system and any applicable fee schedules for NEXPLANON as soon as possible. The price has been communicated to pricing services. HCPCS Labeler 10 Digit NDC 11 Digit NDC Package Description WAC…

Read More
Now Available 02/14/2023

Tivdak J9273 Now Available - 4/6/22

96 J9273 Now Available preheader__here --> J-Code J9273. Effective April 1, 2022. Tivdak (tisotumab vedotin-tftv, for injection 40 mg) has been issued a permanent J-code: J9273 . See Indication, BOXED WARNING, and Important Safety Information below. Indication TIVDAK is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. This indication is approved…

Read More
J-Code 02/14/2023

Apretude Permanent J-Code ‌Now Available: J0739 - 6/24/22

Permanent J-Code now available for this product 96 ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ Having trouble reading this email? Click here . This email was funded and developed by ViiV Healthcare.

Read More
Previous
1 … 1617
Next

No alerts match your filters.

BuyandBill.com — Physician Administered Drug Pricing

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association).

CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved

Review us on Trustpilot
  • Email us [email protected]

Tools & Lookups

  • Search
  • HCPCS Code Lookup
  • NDC Lookup
  • Drug Price Lookup
  • Billing Calculator
  • Drug Comparative Graphing
  • Biosimilar Analysis
  • Part B Reimbursement
  • All Drug Codes

Coding References

  • CPT Administration Codes
  • HCPCS Modifiers
  • HCPCS Approvals
  • Medically Unlikely Edits
  • Place of Service Codes
  • NDC Listing Errors
  • SAD Exclusion List
  • Wastage Guidance (JZ & JW)

Learn

  • Blog
  • Newsletter
  • Bobbi Buell's Newsletter
  • Glossary
  • Buy-and-Bill Basics
  • Biosimilars
  • 505(b)(2)
  • Drug Shortages

Solutions

  • Drug Sponsorship
  • Drug Market Research

Company

  • About B&B
  • Subscription Options
  • Contact Us
  • Schedule a Consultation
  • Sitemap

© 2026 BuyandBill.com, a product of Alchemy Healthcare Solutions LLC. All rights reserved

  • Privacy Policy
  • Terms of Service
BuyandBill.com Analytics

Chart a whole drug class in one screen.

The Comparative Report puts ASP, the Medicare payment limit, WAC and AWP for up to 15 drugs on one timeline. Ten-plus years of monthly history, per HCPCS unit.

  • Four benchmarks plus the ASP/WAC ratio on the same axis
  • Prebuilt biosimilar, therapeutic-area and mechanism groups
  • Index to 100 to compare a $7 drug against a $90 one
  • Sortable table, reference multiples, saved reports, PDF export
See it in action

Included with BuyandBill Pro for $37/month billed annually.

Trastuzumab class, seven products

7 of 7products fell
▼ 90.0%steepest decline
8.6×price spread
The Comparative Report showing seven trastuzumab products: ASP range $7.73 to $66.27, median $27.16, prices fell 7 of 7, and all seven ASP curves plotted from 2015 to 2026.

Actual published ASP, Jan 2015 to Aug 2026.